文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

台湾HIV-1传播性耐药高流行及与病毒学失败和抑制时间相关因素

High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

台湾2018至2020年164例初治HIV-1感染者队列显示,传播性耐药(TDR)患病率为27.4%且呈上升趋势,NNRTI相关突变最常见(21%),InSTI相关TDR较低(1.3%)。基线HIV-1病毒载量≥100 000 copies/mL与更短病毒学失败时间和更长病毒抑制时间相关,InSTI为基础方案与更短病毒抑制时间相关。

要点

  • 台湾初治HIV-1感染者TDR患病率27.4%,2018至2020年呈上升趋势。
  • 基线病毒载量≥100 000 copies/mL与更短病毒学失败时间和更长病毒抑制时间相关。
  • InSTI为基础方案与更短病毒抑制时间相关,不同InSTI方案不影响结局。

核心结论

  • 台湾2018至2020年HIV-1 TDR患病率呈上升趋势,基线病毒载量和InSTI为基础方案是病毒学失败或抑制时间的重要相关因素。

研究设计与样本

  • 研究纳入台湾2018至2020年164例HIV-1初治患者,收集血标本用斯坦福大学HIV耐药数据库判定基因型耐药,采用Cox比例风险模型分析因素。

主要发现

  • TDR患病率为27.4%,2018至2020年呈上升趋势。
  • NNRTI相关TDR突变最常见(21%),InSTI相关TDR处于较低水平(1.3%)。
  • 基线HIV-1病毒载量≥100 000 copies/mL与更短病毒学失败时间相关(多因素风险比7.84;P=0.018)。
  • 基线HIV-1病毒载量≥100 000 copies/mL与更长病毒抑制时间相关(多因素风险比0.46;P<0.001)。
  • 接受InSTI为基础方案的患者病毒抑制时间更短(多因素风险比2.18;P=0.006)。

关键数值与推荐

  • TDR患病率27.4%,NNRTI相关TDR 21%,InSTI相关TDR 1.3%。
  • 基线病毒载量≥100 000 copies/mL:病毒学失败多因素风险比7.84(P=0.018),病毒抑制多因素风险比0.46(P<0.001)。
  • InSTI为基础方案:病毒抑制多因素风险比2.18(P=0.006)。
  • 不同InSTI为基础方案作为初始治疗不影响治疗结局。

临床怎么用

  • 对初治HIV-1感染者应关注基线病毒载量,≥100 000 copies/mL提示病毒学失败风险更高且抑制时间更长。
  • InSTI为基础方案可缩短病毒抑制时间,不同InSTI方案间治疗结局无差异。
  • 台湾地区TDR患病率较高且上升,提示初治前基因型耐药检测可能有助于方案选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Integrase strand transfer inhibitor (InSTI)-based regimens have become the major first-line treatment for HIV-1-infected patients in Taiwan. Transmitted drug resistance (TDR) and several clinical characteristics are associated with time to virological failure or viral suppression; however, these have not been investigated in Taiwan. OBJECTIVES: To determine the impact of several factors on treatment outcomes in HIV-1-infected patients in Taiwan. METHODS: The cohort included 164 HIV-1 treatment-naive patients in Taiwan from 2018 to 2020. Blood specimens were collected to determine the genotypic drug resistance using the Stanford University HIV drug resistance database. Cox proportional hazards models were used to identify factors associated with time to virological failure or viral suppression. RESULTS: The prevalence of TDR in Taiwan was 27.4% and an increasing trend was seen from 2018 to 2020. TDR mutations related to NNRTIs were the most prevalent (21%) while TDR to InSTIs remained at a relatively low level (1.3%). A baseline HIV-1 viral load of ≥100 000 copies/mL was associated with a shorter time to virological failure [multivariate hazard ratio (mHR) 7.84; P = 0.018] and longer time to viral suppression (mHR 0.46; P < 0.001). Time to viral suppression was shorter in patients receiving InSTI-based regimens (mHR 2.18; P = 0.006). Different InSTI-based regimens as initial treatment did not affect the treatment outcomes. CONCLUSIONS: This study found an increasing trend of HIV-1 TDR prevalence from 2018 to 2020 in Taiwan. Baseline HIV-1 viral load and receiving InSTI-based regimens are important factors associated with time to virological failure or viral suppression.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Huang SW, Shen MC, Wang WH, et al. High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan. J Antimicrob Chemother. 2021. PMID: 34648632. doi:10.1093/jac/dkab361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。